1. Market Research
  2. > Pathology
50 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Biopsy Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Technology ; Application ; and Geography

  • $ 4550
  • May 2020
  • 196 pages

These limitations are particularly observed in cases of lymphoma diagnosis.

  • Biopsy
  • Diagnostics
  • Injectable Delivery
  • Lymphoma
  • Medtronic, Inc.

Regenerative Medicine - Thematic Research

  • $ 1950
  • November 2019
  • 24 pages

Yescarta is a CAR-T therapy indicated for patients with certain types of B-cell lymphoma.

  • Lymphoma
  • Regenerative Medicine
  • DiscGenics, Inc.
  • Medtronic, Inc.
  • ViaCyte, Inc.

Europe Biopsy Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product, Technology, Application, and Country

  • $ 3000
  • July 2020
  • 159 pages

These limitations are particularly observed in cases of lymphoma diagnosis.

  • Biopsy
  • Diagnostics
  • Injectable Delivery
  • Lymphoma
  • Medtronic, Inc.

Global Compression Garments Market – Analysis By Product Type, By End User, By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)

  • $ 2400
  • May 2020
  • 190 pages

Dermatologists also recommend surgery to wear compression garments to avoid swelling and bruising of the operated area. compression garments for patients with lymphoma, burns, and varicose veins in an effort to increase quality of life.

  • Apparel
  • Lymphoma
  • World
  • Market Size
  • Medtronic, Inc.

mHealth Solutions Market by Connected Devices, Apps, Services - Global Forecast to 2025

  • $ 4950
  • February 2020
  • 290 pages

(US) FOCUS ON LYMPHOMA APP CHEMO BRAIN DOC NOTES AMERICAN SOCIETY OF CLINICAL ONCOLOGY (US) CARE ZONE, INC.

  • Application
  • Healthcare
  • Lymphoma
  • United States
  • Medtronic, Inc.

Tissue Engineering Market to 2027 - Global Analysis and Forecasts by Tissue Type ; Application, and Geography

  • $ 4550
  • March 2020
  • 163 pages

Gene therapy and cell therapy are transforming the cancer treatment landscape; for example, Novartis Kymriah is used in the treatment of diffuse large B-cell lymphoma.

  • Lymphoma
  • Medical Biotechnology
  • Tissue Engineering
  • Forecast
  • Medtronic, Inc.

Global Endoscopy Devices Market - Opportunities and Forecast (2013-2023)

  • $ 2400
  • January 2019
  • 310 pages

Lymphoma Myeloma Leukemia Unspecified primary sites Source: World Health Organization U. S.

  • Endoscopic Device
  • Lymphoma
  • World
  • Market Size
  • Medtronic, Inc.

Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

  • $ 4550
  • June 2020
  • 184 pages

The wearable injectors market was valued at US$ 5,791.23 million in 2019 and is projected to reach US$ 13,880.88 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020-2027. Wearable injectors ...

  • Autoimmune Disease
  • Diabetes
  • Lymphoma
  • Forecast
  • Medtronic, Inc.

Blood Purification Equipment Market to 2027 - Global Analysis and Forecasts by Product; End User, and Geography

  • $ 4550
  • October 2019
  • 148 pages

For instance, more than ##. ## million people are suffering from leukemia, lymphoma, or myeloma.

  • Healthcare
  • Lymphoma
  • Forecast
  • Market Size
  • Medtronic, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

  • $ 1995
  • April 2020
  • 133 pages

Product Discontinuations: Weakness GSK discontinued the global development of GSK-##, which was in Phase I clinical development for relapsed or refractory small-cell lung cancer; and GSK- ##, which was in Phase I trials for follicular lymphoma, diffuse large B-cell

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Russia
  • Medtronic, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

  • $ 1995
  • March 2020
  • 130 pages

Product Recall: GSK discontinued the global development of GSK-## in Phase I development for relapsed or refractory small-cell lung cancer; and GSK-## in Phase I development for follicular lymphoma, diffuse large B-cell lymphoma, solid tumors, and refractory multiple myel

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Israel
  • Medtronic, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

  • $ 1995
  • November 2019
  • 144 pages

GSK discontinued the global development of GSK-## in Phase I development for relapsed or refractory small-cell lung cancer, and GSK-## in Phase I development for follicular lymphoma, diffuse large B-cell lymphoma, solid tumors, and refractory multiple myeloma.

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Philippines
  • Medtronic, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland

  • $ 1995
  • April 2020
  • 162 pages

R& D Capabilities: Product Discontinuations: Weakness GSK discontinued the global development of GSK-##, which was in Phase I clinical development for relapsed or refractory small-cell lung cancer; and GSK- ##, which was in Phase I trials for follicular lymphoma, diffuse large

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Poland
  • Medtronic, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

  • $ 1995
  • November 2019
  • 180 pages

It also discontinued GSK-## in Phase I stage of development for follicular lymphoma, diffuse large Bcell lymphoma, solid tumor, and refractory multiple myeloma.

  • Lymphoma
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Medtronic, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico

  • $ 1995
  • August 2019
  • 120 pages

Product Recall: GSK discontinued the global development of GSK-## in Phase I stage of development for relapsed or refractory small-cell lung cancer; and GSK-## in Phase I stage of development for follicular lymphoma, diffuse large B-cell lymphoma, solid tumor and refracto

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Mexico
  • Medtronic, Inc.

Global Regenerative Medicine Market 2018-2022

  • $ 2500
  • April 2018
  • 134 pages

Approximately ##% of clinical trials of regenerative medicine are being conducted in oncology indications such as leukemia, lymphoma, brain cancer, breast cancer, bladder cancer, cervix cancer, colon cancer, esophageal cancer, ovarian cancer, and pancreatic cancer.

  • Lymphoma
  • Regenerative Medicine
  • Medtronic, Inc.
  • MiMedx Group, Inc.
  • Organogenesis, Inc.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

  • $ 1995
  • May 2019
  • 130 pages

Leading Market Position: Product Recall: GSK discontinued the global development of GSK-## in Phase I stage of development for relapsed or refractory small-cell lung cancer, as well as the development of GSK-## in Phase I stage of development for follicular lymphoma, diffuse large

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Spain
  • Medtronic, Inc.

Endoscopy Devices Global Market – Forecast To 2025

  • $ 4950
  • February 2019
  • 602 pages

THE ENTEROSCOPIC PROCEDURE IS USED TO TREAT AND DIAGNOSE DIFFERENT TYPES OF SMALL BOWEL CONDITIONS LIKE AMYLOIDOSIS, CELIAC SPRUE, CROHN' S DISEASE, VITAMIN B## DEFICIENCY, GIARDIASIS, INFECTIOUS GASTROENTERITIS, LYMPHOMA AND WHIPPLE' S DISEASE, SMALL BOWEL TUMORS.

  • Endoscope
  • Lymphoma
  • World
  • Market Size
  • Medtronic, Inc.

Mexico Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags and Others

  • $ 5995
  • July 2019
  • 322 pages

Mexico Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags and Others Summary GlobalData’s new ...

  • Hospital
  • Lymphoma
  • Wound Care
  • Mexico
  • Medtronic, Inc.

Italy Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags and Others

  • $ 5995
  • July 2019
  • 317 pages

Italy Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags and Others Summary GlobalData’s new ...

  • Lymphoma
  • Wound Care
  • Italy
  • Southern Europe
  • Medtronic, Inc.
View report >

Life Sciences Market in Israel and Middle East

  • January 2019
  • 116 pages
  • Lymphoma
  • Pharmaceutical
  • Israel
  • Middle East
  • Medtronic, Inc.

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on